PL377878A1 - Sól sodowa rizedronianu o bardzo niskiej zawartości żelaza - Google Patents

Sól sodowa rizedronianu o bardzo niskiej zawartości żelaza

Info

Publication number: PL377878A1
Authority: PL; Poland
Prior art keywords: iron; risedronate sodium; low content; sodium; combination
Prior art date: 2003-01-17

Application number

PL377878A

Other languages

English (en)

Inventor

Revital Lifshitz-Liron

Rami Lidor-Hadas

Nissm Sasson

Igor Lifshitz

Original Assignee

Teva Pharmaceutical Industries Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-01-17

Filing date

2004-01-16

Publication date

2006-02-20

2004-01-16 Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.

2006-02-20 Publication of PL377878A1 publication Critical patent/PL377878A1/pl

Links

XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title abstract 6
IIDJRNMFWXDHID-UHFFFAOYSA-N Risedronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CC1=CC=CN=C1 IIDJRNMFWXDHID-UHFFFAOYSA-N 0.000 title abstract 4
229960000759 risedronic acid Drugs 0.000 title abstract 4
229910052742 iron Inorganic materials 0.000 title abstract 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
238000013019 agitation Methods 0.000 abstract 1
239000007788 liquid Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
238000010992 reflux Methods 0.000 abstract 1
229910052708 sodium Inorganic materials 0.000 abstract 1
239000011734 sodium Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Physical Education & Sports Medicine (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Rheumatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Orthopedic Medicine & Surgery (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Manufacture Of Iron (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Manufacture And Refinement Of Metals (AREA)

PL377878A 2003-01-17 2004-01-16 Sól sodowa rizedronianu o bardzo niskiej zawartości żelaza PL377878A1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US44106203P	2003-01-17	2003-01-17
US44513903P	2003-02-05	2003-02-05

Publications (1)

Publication Number	Publication Date
PL377878A1 true PL377878A1 (pl)	2006-02-20

Family

ID=32776044

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL377878A PL377878A1 (pl)	2003-01-17	2004-01-16	Sól sodowa rizedronianu o bardzo niskiej zawartości żelaza

Country Status (11)

Country	Link
US (1)	US7358360B2 (pl)
EP (1)	EP1583768B1 (pl)
JP (2)	JP3869456B2 (pl)
AT (1)	ATE402942T1 (pl)
CA (1)	CA2513543A1 (pl)
DE (1)	DE602004015407D1 (pl)
ES (1)	ES2311142T3 (pl)
IL (1)	IL169569A (pl)
PL (1)	PL377878A1 (pl)
PT (1)	PT1583768E (pl)
WO (1)	WO2004065397A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUP0300227A2 (hu) *	2003-01-28	2004-09-28	Richter Gedeon Vegyészeti Gyár Rt.	Eljárás nagy tisztaságú 2-szubsztituált -1-(hidroxi-etilidén)-1,1-biszfoszfonsavak és sóik előállítására
US7645459B2 (en)	2004-05-24	2010-01-12	The Procter & Gamble Company	Dosage forms of bisphosphonates
US20080286359A1 (en)	2004-05-24	2008-11-20	Richard John Dansereau	Low Dosage Forms Of Risedronate Or Its Salts
US20080287400A1 (en)	2004-05-24	2008-11-20	Richard John Dansereau	Low Dosage Forms Of Risedronate Or Its Salts
US7645460B2 (en)	2004-05-24	2010-01-12	The Procter & Gamble Company	Dosage forms of risedronate
WO2006129056A2 (en) *	2005-05-28	2006-12-07	Pliva Hrvatska D.O.O	Process and novel salt
JP5354858B2 (ja) *	2006-05-09	2013-11-27	株式会社Ａｄｅｋａ	スルホンアミド化合物の金属塩を含有するポリエステル樹脂組成物
JP2009536639A (ja)	2006-05-11	2009-10-15	アイエヌディー−スイフトラボラトリーズリミテッド	純リセドロン酸または塩を調製するための方法
WO2009050731A2 (en) *	2007-06-20	2009-04-23	Alkem Laboratories Ltd	Novel process for preparing risedronic acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3623397A1 (de) *	1986-07-11	1988-01-14	Boehringer Mannheim Gmbh	Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
SE9901272D0 (sv) *	1999-04-09	1999-04-09	Astra Ab	New improved formulation
US6677320B2 (en) *	2000-01-20	2004-01-13	Hoffmann-La Roches Inc.	Parenteral bisphosphonate composition with improved local tolerance
US6410520B2 (en) *	2000-02-01	2002-06-25	The Procter & Gamble Company	Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
US20030195170A1 (en) *	2002-04-11	2003-10-16	Judith Aronhime	Novel polymorphs and pseudopolymorphs of risedronate sodium
US7645460B2 (en) *	2004-05-24	2010-01-12	The Procter & Gamble Company	Dosage forms of risedronate

2004
- 2004-01-16 PL PL377878A patent/PL377878A1/pl not_active Application Discontinuation
- 2004-01-16 ES ES04702936T patent/ES2311142T3/es not_active Expired - Lifetime
- 2004-01-16 DE DE602004015407T patent/DE602004015407D1/de not_active Expired - Lifetime
- 2004-01-16 US US10/759,919 patent/US7358360B2/en not_active Expired - Fee Related
- 2004-01-16 PT PT04702936T patent/PT1583768E/pt unknown
- 2004-01-16 WO PCT/US2004/001136 patent/WO2004065397A1/en not_active Ceased
- 2004-01-16 EP EP04702936A patent/EP1583768B1/en not_active Expired - Lifetime
- 2004-01-16 CA CA002513543A patent/CA2513543A1/en not_active Abandoned
- 2004-01-16 JP JP2005518469A patent/JP3869456B2/ja not_active Expired - Fee Related
- 2004-01-16 AT AT04702936T patent/ATE402942T1/de not_active IP Right Cessation
2005
- 2005-07-07 IL IL169569A patent/IL169569A/en not_active IP Right Cessation
2006
- 2006-08-07 JP JP2006215059A patent/JP2007008956A/ja active Pending

Also Published As

Publication number	Publication date
EP1583768A1 (en)	2005-10-12
CA2513543A1 (en)	2004-08-05
JP2006515867A (ja)	2006-06-08
WO2004065397A1 (en)	2004-08-05
DE602004015407D1 (de)	2008-09-11
PT1583768E (pt)	2008-09-11
EP1583768B1 (en)	2008-07-30
IL169569A (en)	2010-04-29
ES2311142T3 (es)	2009-02-01
US20040192655A1 (en)	2004-09-30
ATE402942T1 (de)	2008-08-15
US7358360B2 (en)	2008-04-15
JP2007008956A (ja)	2007-01-18
JP3869456B2 (ja)	2007-01-17

Legal Events

Date	Code	Title	Description
2013-12-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
PT1583768E (pt)	2008-09-11	Processo de redução do teor de ferro em risedronato de sódio
MY164311A (en)	2017-12-15	Process to remove impurities from triacylglycerol oil
MY148869A (en)	2013-06-14	Methods for reducing the viscosity of treatment fluids comprising diutan
AU6795400A (en)	2001-03-19	Methods and devices for reducing the mineral content of a region of non-intimal vascular tissue
GB2431681A (en)	2007-05-02	Metal-mediated viscosity reduction of fluids gelled with viscoelastic surfactants
MX2012000286A (es)	2012-02-08	Mejora en el desempeño de la reduccion de friccion en agua que contiene iones multivalentes.
SG145635A1 (en)	2008-09-29	Methods for lubricating a transmission
MY153414A (en)	2015-02-13	Slurry compositions and methods for making same
NO20053229L (no)	2006-01-03	Tettende blanding og fremgangsmate for a tette en del av en underjordisk formasjon.
TW200726824A (en)	2007-07-16	Cleaning compound and method and system for using the cleaning compound
MX2010008407A (es)	2010-09-07	Desactivacion de una composicion explosiva utilizando enzimas.
EP1298205A4 (en)	2004-06-16	NEW LIPASE
MY148921A (en)	2013-06-14	Enzymatic oil interesterification
MA37554A1 (fr)	2018-03-30	Composition de liant hydraulique
WO2007021617A3 (en)	2007-04-26	Dosage efficient, storage stable compositions for reducing chromium (vi) in cement
TW200718740A (en)	2007-05-16	Compositions effective to suppress void formation
BR0306699A (pt)	2005-04-26	Sistema de células de combustìvel, método para preparar uma emulsão bicontìnua, emulsão bicontìnua, método para prevenir corrosão de uma superfìcie metálica, e, composição
MY145842A (en)	2012-04-30	Method of producing triethanolamine
PE20040429A1 (es)	2004-08-09	Proceso para el beneficio de minerales sulfurados
TW200640496A (en)	2006-12-01	Visco-supplement composition and methods
MX2007004816A (es)	2007-07-09	Composicion detergente.
TNSN05021A1 (en)	2007-05-14	Method and installation for the production of lime water from deionised water
MXPA05010837A (es)	2005-12-14	Aditivo para reducir la contraccion para composiciones de cemento.
MXPA05013595A (es)	2006-03-09	Proceso para aumentar la extraccion de liquido de las telas.
WO2007122395A3 (en)	2008-01-10	Compositions comprising maltodextrin and associated methods